Skip to content

A Comparative Pharmaceutical -Clinical Study Of Amritadi Ghrita Prepared By Two Different Media and Its Effect on Gout

A Comparative Pharmaceutical Study Of Amritadi Ghrita Prepared by Desi Cow Milk and Jersey Cow Milk and Its Effect on Vatarakta With Special Reference To Gout - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076555
Enrollment
60
Registered
2024-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

GOVERNMENT PG AYURVEDIC COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender in the age group between 20-60 years. 2. Patients who fulfilled the diagnostic criteria. 3. Patients who have serum uric acid level more than 7mg/d in males and more than 6mg/dl in females with or without any associate feature like joint pain and inflammation. 4. Disease presenting with classical clinical feature of Vatarakta like, Sandhi shool (Joint pain), Sandhi shotha (Swelling of joint), Sparsha asahatvam (Tenderness), Raga (Redness), Twak vaivarnya (Discolouration of skin) and Vidaha(Burning sensation). 5. Patients who are willing to participate in trial.

Exclusion criteria

Exclusion criteria: 1. Patients who are not willing to participate in trial. 2. Patients below the age of 20 years and above 60 years of age. 3. Patient having chronic symptoms of Vatarakta along with other deformities. 4. Patients who are suffering from any other form of arthritis like Osteoarthritis, Tubercular Arthritis, Rheumatoid Arthritis etc. 5. Patients who are suffering from chronic renal, respiratory, cardiac or hepatic disorder. Patients who have any malignancy. 6. Patients who are pregnant and lactating mother

Design outcomes

Primary

MeasureTime frame
Improvement in reduction of increased Uric acid and Symptomatic reliefTimepoint: Within 14 days

Secondary

MeasureTime frame
Normal level of Uric acid & complete symptomatic reliefTimepoint: With in 30 days

Countries

India

Contacts

Public ContactDR AJAY KUMAR

Government P.G Ayurvedic College And Hospital

drankitg01@gmail.com9532016160

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026